Siti Rahmayanti is an expert in Immunology at Boston Children's Hospital (United States). Siti Rahmayanti has authored 27 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 67 (community average: 125). How the SLR is computed.

LeadR Profile

Siti Rahmayanti Boston Children's Hospital United States
67 ScienceLeadR Reputation 67
Network Map

Immunology

Subspecialties: Surgery - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2019 - 2026

Source: PubMed

Boston Children's Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hyperinnervation inhibits organ-level regeneration in mammalian skin.
PMID 41864207 — skin, cells, fibroblasts, tissues
Cell Top journal20260
Moving to 3D: Quantifying Virtual Surgical Planning Accuracy Using Geometric Morphometrics and Cephalometrics in Facial Feminization Surgery.
PMID 40249638 — genioplasty, feminization, surgery, plastic
J Craniofac Surg20251
Invasion of spontaneous germinal centers by naive B cells is rapid and persistent.
PMID 38517953 — immune system phenomena, epitopes, germinal center, adoptive transfer, clone cells, b-lymphocytes
Sci Immunol20243
Testosterone Promotes Nerve Tethering and Acellular Biomaterial Perineural Fibrosis in a Rat Wound Repair Model.
PMID 38775428 — biocompatible materials, cells, fibrosis, cicatrix, tissues, testosterone
Adv Wound Care (New Rochelle)20241
Systematic review: genetic polymorphisms in the pharmacokinetics of high-dose methotrexate in pediatric acute lymphoblastic leukemia patients.
PMID 39002021 — precursor cell lymphoblastic leukemia-lymphoma, leukemia, polymorphism, genetic, therapeutics, methotrexate, pharmacokinetics
Cancer Chemother Pharmacol20242

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 1

By status:

Completed 1

By type:

Observational 1

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 1

LeadR Networks

Main global connection map